Additional experiments have shown that estrogen-dependent oncogenic effects in two ovarian cancer cell lines, CAVO-3 and BG-1, can be reversed by introducing miR-206 mimics in ERα+ovarian cancer cells. This evidence concerns the gene ESR1 and ovarian cancer.